Low serum level of hepatitis B core‐related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapyAkihiro Matsumoto, Kendo Kiyosawa, Eiji Tanaka et al.|Hepatology Research|2007Cited by 83
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammationHaruki Uojima, Masashi Mizokami, Hisashi Hidaka et al.|Journal of Gastroenterology|2024Cited by 23
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus EliminationYuta Myojin, Tetsuo Takehara, Hayato Hikita et al.|Hepatology Research|2025Cited by 3